Bilateral Breast Reduction Research Articles

Neighborhood Disadvantage Predicts Delay in Care in Bilateral Breast Reduction.

The Area Deprivation Index (ADI) is a validated quantifiable measure of neighborhood disadvantage and social determinants of health (SDoH). Higher percentiles in ADI correlate with the most disadvantaged neighborhoods: lower income, lower education, and less access to transportation. Using ADI, we aimed to investigate the impact of SDoH on bilateral breast reduction (BBR) complication rates. A retrospective study of BBR patients from 2015 to 2021 was conducted. Patient addresses were matched to ADI percentiles and grouped into most (top 80% ADI) and least disadvantaged. Multivariable regressions were used to compare postoperative treatment between groups and adjust for confounders. In total, 568 patients were analyzed and 47% were high ADI. Time-to-event analysis revealed a 155% (β = 2.55; CI, 1.87-3.48; P < 0.001) increase in time to presentation for treatment of wound-related complications among higher-deprivation patients compared to their lower-deprivation counterparts. This difference in time to presentation equated to approximately 3 days overall when comparing higher to lower deprivation patients; however, this difference between the groups increased to 12 days when comparing those who experienced wound-related complications beyond day 30. High deprivation was associated with increased delays to treatment after complications. More research is needed to determine the factors that impact postoperative courses among high ADI patients.

Is Migraine Surgery Financially Viable for the Hospital and Surgeon? A Single-Surgeon, Ten-Year Study at an Academic Institution.

Data exists to demonstrate that migraine surgery is cost-effective for the long-term treatment of headaches, but no data exists regarding its financial viability for healthcare institutions. The goals of the current study are to demonstrate that (1) migraine surgery is financially viable for an academic institution with a net-positive profitability and (2) migraine surgery is a sought-after therapy that can draw patients into the healthcare system. A retrospective chart review of migraine and bilateral breast reduction (BBR) consults seen in clinic between 05/01/2011-05/30/2020 was conducted. Patient age, sex, payor information, and distance from the hospital was collected. Profit margin, percentage profit, collection percentage, and conversion rate to surgery from clinic was calculated. 407 new migraine consults and 119 new BBR consults were included from which, 150 underwent migraine surgeries and 117 underwent BBR respectively. Migraine surgery group came from a further distance for the initial consult (P-value<0.001) and for surgery (P-value<0.001). There were also more migraine surgery patients from out-of-state (P-value=0.012). Migraine clinic patients had a larger ratio of private insurers (P-value<0.001). Migraine surgery patients had a greater total charge (P-value<0.001), estimated reimbursement (P-value=0.001), and total cost (P-value<0.001). This study provides evidence that migraine surgery is financially viable for hospitals and while performing similarly to bilateral breast reduction in profit margin, it brought in more patients from outside the catchment area of our institution. These findings may encourage hospitals to recruit migraine surgeons to improve care for this underserved patient population.

Variability in Postoperative Nipple Sensation by Dermoglandular Pedicle in Bilateral Breast Reduction

Variability in Postoperative Nipple Sensation by Dermoglandular Pedicle in Bilateral Breast Reduction

Incidence of Hematoma Following Breast Reduction in Patients Taking Selective Serotonin Reuptake Inhibitor or Serotonin-Norepinephrine Reuptake Inhibitor: A Retrospective Review.

Background Selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) use is more common in the plastic surgery population compared to the general population. This study was designed to assess the theoretical effect of SSRIs and SNRIs on platelet function and the potential for increased bleeding risk. This study sought to establish the incidence of postoperative bleeding following routine bilateral breast reduction for patients on SSRIs or SNRIs. The outcomes of this study contribute to the discussion of whether these medications should be discontinued before elective surgery. Methodology A retrospective chart review of all patients who received bilateral breast reduction surgery over a 10-year period was performed. Patient charts were reviewed for postoperative hematoma formation as well as medications being used around the time of surgery. The rate of hematoma formation in patients actively taking SSRIs or SNRIs at the time of surgery was compared with the rest of the study population. Results A total of 1,022 patients met the inclusion criteria for the study. The overall incidence of postoperative hematoma was 7.7%. Of these, 1.9% of patients had clinically significant hematomas that required operative evacuation, and the remaining were treated conservatively. The only variable associated with a significantly higher risk of hematoma formation was advanced age (p = 0.005). Conclusions There was no significant difference in hematoma incidence after breast reduction in patients taking SNRIs or SSRIs compared with the general population. This contradicts some of the previously published literature and can hopefully guide clinicians in counseling their patients preoperatively.

Randomized Controlled Trial to Assess Negative Pressure Wound Therapy versus Standard-of-care Dressings in Breast Surgery: A Pilot Study.

Standard breast reduction dressings such as Prineo are used to cover surgical wounds, in combination with a binder or support bra. The Prevena Restor BellaForm is a negative pressure wound therapy dressing that covers the entirety of the breast mound and is purported to provide further support and reduce swelling. The aim of this study was to compare the Restor to standard-of-care dressings. The study was a randomized control trial of women undergoing bilateral breast reduction with one breast being dressed with the Prevena Restor BellaForm dressing and the other having standard of care (Prineo). Outcomes measured were drain outputs, postoperative length of stay, quality of scarring, patient preference for dressings, and adverse events. Follow-up was at 1, 2-6, and 26 weeks. The results show a reduction in postoperative days 1 and 2 average drain output on the Restor side compared with standard dressings. Patient-reported outcome measures showed less bruising. There was no difference in postoperative length of stay and no difference in appearance of scars at the 26-week follow-up period. One patient required removal of the dressing due to irritation and one patient required assistance with resealing of the vacuum. We have shown benefits to drain output and comfort using close incisional negative pressure therapy in breast reduction mammaplasty. We plan to continue to investigate close incisional negative pressure therapy in larger comparative trials for other breast procedures including implant-based reconstruction, where a reduction in drain output could be of great benefit to both healing and reduction of infection risk.

Exploring Complication Rates: A Comparative Study of Breast Reduction and Combined Breast Reduction with Abdominoplasty.

Despite a trend towards combining abdominoplasty with breast reduction surgery, so called "mommy makeovers", the safety of this combined approach has been the subject of debate, with previous research yielding conflicting results. We evaluated the risk for complications and revision associated with adding abdominoplasty to bilateral breast reduction surgery. We conducted a 10-year single-center retrospective chart review of bilateral breast reduction patients in Nova Scotia. Univariate and multivariate analyses were performed to compare the risk for complication and revision in patients with bilateral breast reduction to those with a concomitant abdominoplasty. Of the 1871 patients initially screened, 738 were included. 44 underwent a concomitant abdominoplasty procedure. Compared to the breast reduction alone group, patients with concomitant abdominoplasty were significantly older (47.5±9.9 vs. 42.8±13.2, p=0.004), had a higher BMI (28.1±4.4 vs. 25.8±3.1, p<0.001), and experienced longer operating room times (226±6 vs. 115±3 mins, p<0.001). In multivariate analysis, concomitant abdominoplasty did not increase the risk for breast-related (OR: 0.86 95%CI 0.43-1.7, p=0.668) or total complications (OR: 1.63, 95%CI 0.83-3.19, p=0.154). However, there was a trend towards an increased risk of breast revision (OR: 2.684, 95%CI 0.95-7.6, p=0.062) and a significantly increased risk of total revision (OR: 6.624, 95%CI 2.7-16.1, p<0.001). Moreover, patients with concomitant abdominoplasty experienced more follow-up visits (median: 4 vs. 3 visits, p=0.042). In our single-center retrospective analysis, combining abdominoplasty with bilateral breast reduction did not increase the risk for breast, or total complications; however, it did increase the risk for total revisions. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

Quality Improvement Initiative: Utilization of Video Postoperative Instructions in Breast Reduction Enhances Patient Experience

Abstract Goals/Purpose The current standard of care for providing postoperative instructions to patients undergoing elective, ambulatory surgeries often falls short in efficiency, clarity, and patient-centeredness. Patients are given a single set of written instructions at the time of discharge after their surgery, which often leads to confusion and increased reliance on phone calls, urgent clinic appointments, and even unnecessary visits to the emergency department. Recognizing this, we propose a quality improvement initiative to enhance postoperative instructions for breast reduction patients through a video format. Methods/Technique With institutional IRB approval, all adult patients undergoing bilateral breast reduction (CPT 19318) at an urban academic hospital were included over a 3-month period. A 2-minute video with standardized narrative instructions and visual aids was created. Patients viewed the video during the preoperative visit, and a QR code link to the video was provided in the visit summary on the day of surgery. A Spanish version of the video was available if a Spanish interpreter was used during informed consent. The number of phone calls and emergency department visits within 30 days were recorded and compared to a cohort of patients before this intervention. Qualitative surveys were administered pre- and post-operatively to collect patient feedback. Results/Complications During the study period, 59 patients received breast reduction surgery and were given the standardized video instructions pre- and post-operatively (video group). In comparison, 75 breast reduction patients from the prior 3 months, who received nonstandardized, written instructions post-operatively, served as the control group. In the video group, 47% of patients (28 out of 59) made at least one phone call to the clinic, averaging 0.7 calls per patient, while 56% of the control group patients (42 out of 75) made at least one phone call, averaging 1.1 calls per patient. Categorizing reasons for the calls, there was a significantly higher proportion of calls related to wound dehiscence or minor drainage in the video group (41%) compared to the control group (22%; p=0.03). This shift may be attributed to a reduction in routine postoperative care questions due to the clarity provided by the video instructions (FIGURE1). There were 4 unnecessary emergency department visits within 30 days post-surgery in the study period, slightly decreased from the control period's 6 visits (after excluding 1 visit with the patient diagnosed with pulmonary embolism); however, the difference was not statistically significant. Fifteen patients who received the video instruction completed a survey, with 80% rating the video as very helpful, and 80% were able to access the QR code without assistance. These patients scored an average of 81 out of 100 on satisfaction with information measured using the BREAST-Q module after receiving the video instruction. There was no difference in complication between the two groups of patients. Conclusion Video instruction proves to be a viable format for patient education and postoperative instruction, offering consistency, multilingual support, and enhanced learning through visual aids. Patient acceptance is high, indicating good baseline digital literacy and encouraging the use of this technology among surgery providers.

Experience with Registered Nurse First Assistants (RNFA) vs General Practitioner Surgical Assistants (GPSA) in Bilateral Breast Reduction

Experience with Registered Nurse First Assistants (RNFA) vs General Practitioner Surgical Assistants (GPSA) in Bilateral Breast Reduction

Do Intraoperative Platelet-Rich Plasma Injections Influence the Final Appearance of Vertical Scars after Breast Reduction? Spectrophotometric Analysis

Background: Platelet-rich plasma (PRP) has been shown to support wound healing and tissue regeneration due to its high concentration of growth factors and cytokines. This study aims to investigate the effect of intraoperative PRP injections on the final appearance of vertical scars after breast reduction, as well as to identify potential predictors of a scar’s aesthetic assessment using spectrophotometric parameters. Methods: In this prospective, randomized trial, 82 scars from 41 women who underwent bilateral breast reduction with an inverted T pattern were analyzed. PRP or a placebo substance (0.9% sodium chloride solution) was injected intraoperatively into the edges of vertical wounds. Spectrophotometric measurements of scar pigmentation were performed 3 and 6 months after surgery; additionally, two independent observers evaluated the aesthetic appearance of scars based on photographs. Results: The results showed that the use of intraoperative PRP injections did not significantly influence the final appearance of vertical scars after breast reduction. Conclusions: We indicated spectrophotometric variables (b) in the early stages of wound healing (after 3 months) that can be predictors of the final scar’s aesthetic outcome. This can be helpful in detecting scars that may need additional interventions to optimize the healing process.

The Role of the Inframammary Fold (IMF) in Aesthetic and Reconstructive Surgery: A Critical Analysis and Surgical Solution

IntroductionThe inframammary fold (IMF) is a critical structure in breast aesthetics and is affected by various types of breast surgery. The ideal IMF has a semi-elliptical shape, which may become attenuated with age and descends in macromastia. The aim of this study was to analyse the IMF and retain/restore its shape with sutures.MethodsA retrospective study was conducted on breast surgeries performed over a four-year period (2019–2022). The morphometry of the IMF was evaluated preoperatively while the patients were standing. In cases where the IMF was symmetrical, sutures were used to reinforce it during surgery. When the loss of the semi-elliptical shape was clinically indicated, the IMF was mobilized, repositioned, and then sutured into place.ResultsThe study included 56 patients: 43 undergoing immediate breast reconstruction, and 13 undergoing bilateral breast reductions. In over two thirds of the patients, the lateral IMF was inferiorly displaced compared to the medial IMF.ConclusionIt is recommended to reinforce the IMF in all patients undergoing breast surgery. Where the IMF has an elliptical shape preoperatively, it is reinforced. Where IMF is inferiorly displaced, mobilization and superior advancement of the IMF, followed by suture reinforcement, are necessary. This approach results in a well-defined IMF with improved breast aesthetics.Level of Evidence IVThis journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

Reply to Comment on "Evaluating the Impact of ACGME Resident Duty Hour Restrictions on Patient Outcomes for Bilateral Breast Reductions".

Reply to Comment on "Evaluating the Impact of ACGME Resident Duty Hour Restrictions on Patient Outcomes for Bilateral Breast Reductions".

Evaluating the Impact of ACGME Resident Duty Hour Restrictions on Patient Outcomes for Bilateral Breast Reductions.

Evaluating the Impact of ACGME Resident Duty Hour Restrictions on Patient Outcomes for Bilateral Breast Reductions.

Variability in Opioid Prescribing Among Plastic Surgery Residents After Bilateral Breast Reduction.

Prescription opioid misuse in the United States accounts for significant avoidable morbidity and mortality. Over one third of all prescriptions written by surgeons are for opioids. Although opioids continue to provide needed analgesia for surgical patients, there are few guidelines in the plastic surgery literature for their safe and appropriate use after surgery. The consequence is wide variability and excessive opioid prescriptions. Understanding patterns of prescribing among plastic surgery residents is a crucial step toward developing safer practice models for managing postoperative pain. The authors performed a retrospective analysis of discharge opioid prescriptions after bilateral breast reduction at a single academic medical center from 2018 to 2021. Single factor 1-way analysis of variance was used to evaluate prescribing patterns by resident, postgraduate year, attending of record, and patient characteristics for 126 patients. A multivariate analysis was performed to determine the degree to which these factors predicted opioid prescriptions. This analysis revealed significant variability among residents prescribing opioids after bilateral breast reductions (P < 0.001) irrespective of patient comorbidities and demographics. Residents were found to be the main predictor of opioid prescriptions after surgery (P < 0.001) with a greater number of morphine milligram equivalents prescribed by the more junior residents (P < 0.001). Excessive and variable opioid prescriptions among plastic surgery residents highlight the need for opioid prescribing education early in surgical training and improved oversight and communication with attending surgeons. Furthermore, implementation of evidence-based opioid-conscious analgesic protocols after common surgical procedures may improve patient safety by standardizing postoperative analgesic prescriptions.

Evaluating the Impact of ACGME Resident Duty Hour Restrictions on Patient Outcomes for Bilateral Breast Reductions.

Bilateral breast reductions performed in the 3 years before and after each reform were collected from the National Inpatient Sample database: pre-duty hours (2000-2002), duty hours (2006-2008), and extended duty hours (2012-2014). Multivariable logistic regression models were constructed to investigate the association between ACGME duty hour restrictions on medical and surgical complications. Overall, 19,423 bilateral breast reductions were identified. Medical and surgical complication rates in these patients increased with each successive iteration of duty hour restrictions (P < 0.001). The 2003 duty-hour restriction independently associated with increased surgical (OR = 1.51, P < 0.001) and medical complications (OR = 1.85, P < 0.001). The 2011 extended duty-hour restriction was independently associated with increased surgical complications (OR = 1.39, P < 0.001). ACGME duty-hour restrictions do not seem associated with better patient outcomes for bilateral breast reduction although there are multiple factors involved. These considerations and consequences should be considered in decisions that affect resident quality of life, education, and patient safety.

26. Opioid Prescribing Patterns among Plastic Surgery Residents for Bilateral Breast Reduction

Background: Prescription opioid misuse in the United States accounts for significant avoidable morbidity and mortality. Surgeons are responsible for more than a third of opioid prescriptions. Although opioids continue to provide needed analgesia for surgical patients, there are only sporadic guidelines in the plastic surgery literature for their safe and appropriate use after surgery. The consequence is wide variability and excessive opioid prescriptions. Understanding patterns of prescribing among plastic surgery residents is an important step toward developing safer practice models for managing post-operative pain. Opioid prescribing patterns among plastic surgery residents remains unexplored. Methods: The authors performed a retrospective analysis of post-operative opioid prescriptions after bilateral breast reduction at a single academic medical center from 2018-2021. Single factor one-way ANOVA was used to evaluate prescribing patterns by resident, post-graduate year, attending of record, and patient characteristics (age, race, BMI, smoking status, diagnosis of chronic pain disorder, and mental health diagnosis). A multivariate analysis was performed to determine the degree to which these factors predicted opioid prescriptions. Results: A mean of 131 morphine milligram equivalents (MME) were prescribed by 12 residents for the 126 patients who underwent bilateral breast reductions included in this study. This is over four times the MMEs typically used by patients after this operation. Significant variability in prescribing among residents (p<0.001) was found irrespective of patient characteristics. Additionally, opioid prescriptions were found to differ based on attending (p value< 0.001). However, a multivariate analysis performed based on the variables for the initial ANOVA analyses found that only resident post-graduate year (p<0.001) and resident prescriber (p<0.001) were significant predictors of opioid prescriptions. Conclusion: There is wide variability in plastic surgery resident prescribing after bilateral breast reduction surgery. These prescriptions are often in excess of typical consumption after this operation. Findings highlight residents as a promising target for transforming opioid prescribing, as they were found to be the main predictor of opioid prescriptions after surgery. Thus, overall opioid prescribing can be drastically changed by improving the education of residents and facilitating their decision-making by implementing evidence-based, opioid-conscious analgesic protocols after common plastic surgery operations.

Risk Factors for Major Complications Identified for Patients Undergoing Breast Reduction: Analysis of 31,755 patients in the National Surgery Quality Improvement Program database

Objective: Breast reductions remains one of the most common procedures performed by plastic surgeons annually in the United States. However, recent studies on risk factors leading to complications following this procedure on a national level have been limited. Our study aims to analyze the most recent national data collected and to compare it to previous similar studies. Methods: Our study analyzed retrospective data collected from the American College of Surgeons National Surgery Quality Improvement Program (NSQIP) database between the years 2015-2020. Those who underwent bilateral breast reductions were identified using the Current Procedural Terminology (CPT) code 19318 as their primary procedure. Those undergoing breast cancer related procedures were excluded. Descriptive statistics and chi square analysis were used to further analyze data. Major complications were defined as unplanned readmission or reoperation. Results: A total of 31,755 females were identified, all cancer related cases were excluded. Compared to previous studies, there was nearly double the total cases identified within the database over the last 5 years. Median age was 42.1, average BMI 30.8, and average operative time was 152 minutes. The overall major complication rate was 2.8%, similar to previous studies. Wound complication rate was 4.2%. Statistically significant factors of hypertension, bleeding disorder, diabetes, long-term steroid use, positive smoking status, high BMI and prolonged operative time were associated with increased risk of major complication. There was no significant difference in wound complication rate or major complication rates when stratified by specialty performing breast reductions. Conclusion: Well known risk factors for major complications that were previously identified using the NSQIP database continue to be demonstrated in recent data. These considerations should be taken into account on preoperative evaluation/discussions with patients undergoing breast reductions. Previously unexplored datapoints should be considered in future datasets such as marijuana use to further identify potential risks for complications. Corresponding Author: Ashraf Elzanie, MD, 200 Riverfront Dr. Apt 27C, Detroit, MI 48226

Reimbursement Trends in Reduction Mammoplasty: A Single-Center Analysis of Insurance Reimbursements From 2012 to 2021.

Medicare reimbursement for plastic surgery procedures increased by 2% while inflation increased by 19% in the past decade. Given increasing national breast reduction case volume and the negative impact decreased reimbursements have on surgeon well-being, we sought to evaluate actual surgeon reimbursements for bilateral breast reduction over a decade. A retrospective review was performed including all identifiable breast reduction procedures (Current Procedure Terminology 19318) performed at a tertiary academic hospital between October 2011 and September 2021 (fiscal year 2012-2021). The annual number of patients undergoing breast reduction, the payor, and average yearly amounts reimbursed were evaluated and trended over time. Percent change from Medicare average yearly reimbursements was evaluated and trended over time. All values were adjusted to 2021 US dollars. During our study period, there were 486 bilateral breast reduction procedures with 36 outlier payments; therefore, 450 reimbursements were included in the study. There were 5 payors, and the average adjusted reimbursement amount was $2418.74 ± $1123.83. All private payors had significantly higher average reimbursement than Medicare ( P < 0.0001), and Medicare was the only payor with significant decrease in reimbursement over time (-$58.58 per year, 95% confidence interval, -$110.80 to -$6.33, P = 0.033). Our data demonstrate that a difference exists between public and private payors for bilateral breast reduction procedures. Private payor reimbursements outpaced inflation. Medicare is an unreliable benchmark that may indirectly lead to declining reimbursements over time.

Therapeutic Reduction Mammoplasty: Experience of a Single Institute.

Breast cancer is the most common malignancy in women worldwide as reported by the World Health Organization. The concept of oncoplastic breast surgery appeared as an extension of breast-conserving surgery, applying breast reduction techniques with more acceptable aesthetic and functional outcomes. The purpose of the present study was to describe the breast cancer population of a single institute submitted to lumpectomy and bilateral immediate breast reduction or mastopexy and its complications. This is a retrospective observational study including patients submitted to lumpectomy and immediate bilateral breast reduction or mastopexy. Patients and tumour characteristics, surgical technique, complications, follow-up period, and recurrence data were obtained and analyzed. A total of 49 patients were submitted to lumpectomy and bilateral breast therapeutic reduction/mastopexy, with a mean age of 56.47 ±8.58 years and a mean body mass index of 28.68kg/m2 ±3.94 kg/m² between January 2019 and December 2021. Invasive tumours of no specific type, associated or not, with carcinoma intraductal in situ were the most common histological type corresponding to almost 80% of the cases with T1 stage corresponding to more than half of the cases. Sixteen percent of the patients had early minor complications with wound dehiscence associated with wound delayed healing, corresponding to 75% of the cases. Body mass index had a statistical difference between groups (p=0,006, t-test). The low rates of minor and major complications show that immediate therapeutic breast reduction can be a suitable approach in selected cases.

Retrospective Evaluation of Complications in Patients Who Underwent Breast Reduction Surgery without Drains: No Drain, No Pain!

Aim: In women, breast reduction surgery is performed due to macromastia, i.e., excessive breast size, regardless of age, and is the most effective method for eliminating problems such as dermatitis and malodor under breasts, as well as pain in the musculoskeletal system. Breast reduction surgery is a frequently performed and relatively safe procedure to defer above mentioned symptoms of patients. To contribute the establishment of standards that will ensure maximum patient comfort and minimum complications risk in the follow-up of breast reduction surgery is the main output of this study. For that reason, complications and their associations in this patient group has been compared with the previous studies. Material and Methods: Demographic and surgical record of all women who underwent bilateral breast reduction surgery without liposuction performed by the same surgeon without the use of drains were evaluated retrospectively. Approval of the local ethics committee has been received prior of the study (decision number 10/24). Hence, types of complications and their percentages, statistics related to their age and patients’ surgical measurements has been analyzed statistically. Results: Breast reduction surgery was performed with the superomedial pedicle technique in 22 of the patients and the free nipple graft technique in 9. Early complications were seen in three (1.82%) of the total of 62 breasts that were operated on. There was no statistical correlation between the amount of reduction or nipple elevation level with complications. Conclusion: The use of no drains in breast reduction surgery did not increase postoperative complications when compared to literature, and it also provided a more comfortable follow-up process for both the patient and the surgeon.

Breast Hypertrophy: A Real Pain in the Back.

Bilateral breast hypertrophy comes with signs and symptoms ranging from mild to debilitating. Bilateral breast reduction (BBR) is one of the most frequently performed plastic surgery procedures, and its effects on parameters such as spinal balance, paraspinal muscle function, and physical performance have not been thoroughly evaluated. The objective of this study was to evaluate the effects of BBR using advanced spine imaging modalities, and pain resolution. A prospective, observational, cohort study was carried out at the McGill University Health Centre. The following measures were recorded preoperatively and postoperatively for each patient: patient questionnaires (BREAST-Q and Pain), magnetic resonance imaging, and EOS low-radiation spinal scan. Significant postoperative pain reduction was recorded, and there was up to 148% improvement in physical tests. Improvement in all questionnaire and BREAST-Q categories was documented. Preoperative and postoperative magnetic resonance imaging did demonstrate a statistically significant absence of permanent anatomical skeletal sequelae. Postoperative improvement in thoracic kyphosis was documented. Quality-of-life scores are uniformly improved following BBR. Key findings following BBR include significant pain reduction and no evidence of spinal skeletal change. This is a finding of major importance in view of the practice of many insurance companies/third-party payer and health care systems that use the Schnur scale. The Schnur scale associates a weight for resection with body size that is not directly predictive of pain relief. This may indicate the need for more precise or different guidelines based on these quantitative findings. Therapeutic, IV.